Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

38.10
+1.173.17%
Post-market: 37.97-0.1300-0.34%16:11 EDT
Volume:5.28M
Turnover:199.38M
Market Cap:44.39B
PE:63.50
High:38.11
Open:37.13
Low:37.09
Close:36.93
52wk High:38.11
52wk Low:17.82
Shares:1.17B
Float Shares:1.09B
Volume Ratio:1.00
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.73
PE(LYR):31.49

Loading ...

Lowe’s, Kraft Heinz, Teva, Take-Two, HIVE Insider Shock

TIPRANKS
·
Jun 27

Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback

Simply Wall St.
·
Jun 22

FDA Seeks Updated Labeling for Testosterone Therapies

MT Newswires Live
·
Jun 19

Teva Submits New Drug Application for Ecopipam to Treat Pediatric Tourette Syndrome

MT Newswires Live
·
Jun 19

Teva submits NDA for Ecopipam to FDA

TIPRANKS
·
Jun 19

Teva Releases Q2 2026 Aide Memoire

THOMSON REUTERS
·
Jun 19

Teva - Ecopipam Showed Statistically Significant Benefit on Primary Efficacy Endpoint in Pediatric Patients

THOMSON REUTERS
·
Jun 19

Jefferies continues to like Teva after recent pullback

TIPRANKS
·
Jun 19

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 15

How Investors Are Reacting To Teva (TEVA) AUSTEDO Real‑World Data On Tardive Dyskinesia Improvement

Simply Wall St.
·
Jun 11

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Teva Pharmaceutical (TEVA) and Nuvation Bio (NUVB)

TIPRANKS
·
Jun 10

Teva put volume heavy and directionally bearish

TIPRANKS
·
Jun 09

Teva presents positive long-term study data for Austedo

TIPRANKS
·
Jun 08

Teva’s Data on Austedo® (Deutetrabenazine) Tablets and Austedo Xr® (Deutetrabenazine) Extended-Release Tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care

THOMSON REUTERS
·
Jun 08

Alvotech Says FDA Agreed to Review Application for Biosimilar of Entyvio; Shares Rise Pre-Bell

MT Newswires Live
·
Jun 08

Teva Says AUSTEDO Improves Quality of Life in Huntington's Disease Study

MT Newswires Live
·
Jun 06

Teva announces new data on AUSTEDO tablets, AUSTEDO XR tablets

TIPRANKS
·
Jun 05

Teva launches Ahzantive in Europe

TIPRANKS
·
Jun 04

Teva Pharmaceutical Industries Rolls Out Ahzantive in Europe to Treat Retinal Diseases

MT Newswires Live
·
Jun 04

BRIEF-Teva Expands European Biosimilars Portfolio With Launch Of AHZANTIVE Biosimilar To Eylea

Reuters
·
Jun 04